Clinical Trials Directory

Trials / Completed

CompletedNCT00400621

Effects of Therapeutic Doses of Acetaminophen in Moderate Drinkers

Assessment of Hepatic Injury in Subjects Who Consume Moderate Amounts of Alcohol While Being Administered Therapeutic Doses of Acetaminophen:

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
150 (planned)
Sponsor
Denver Health and Hospital Authority · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The study objective was to evaluate the safety of ten consecutive days of therapeutic acetaminophen dosing in moderate alcohol consumers. The main outcome was liver injury (measured by an increase in mean serum ALT or AST levels). Patients were randomly assigned to 10 days of acetaminophen or placebo. Blood tests were measured at baseline, day 4 and day 11 to look for injury. We hypothesized that there would be no difference in liver enzymes between the two groups.

Conditions

Interventions

TypeNameDescription
DRUGacetaminophen

Timeline

Start date
2003-04-01
Completion
2003-09-01
First posted
2006-11-17
Last updated
2024-07-08

Source: ClinicalTrials.gov record NCT00400621. Inclusion in this directory is not an endorsement.

Effects of Therapeutic Doses of Acetaminophen in Moderate Drinkers (NCT00400621) · Clinical Trials Directory